A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds

A rapid and sensitive assay was developed to analyse the sensitivity of wild type HSV-1 and HSV-2 isolates with respect to a battery of antiviral substances. In the viral sensitivity assay, human embryonic lung fibroblasts are incubated with the virus isolate and different concentrations of the anti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virological methods 1983-01, Vol.6 (3), p.141-149
Hauptverfasser: Wahren, B., Harmenberg, J., Sundqvist, V.-A., Levén, B., Sköldenberg, B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 149
container_issue 3
container_start_page 141
container_title Journal of virological methods
container_volume 6
creator Wahren, B.
Harmenberg, J.
Sundqvist, V.-A.
Levén, B.
Sköldenberg, B.
description A rapid and sensitive assay was developed to analyse the sensitivity of wild type HSV-1 and HSV-2 isolates with respect to a battery of antiviral substances. In the viral sensitivity assay, human embryonic lung fibroblasts are incubated with the virus isolate and different concentrations of the antivirals. After 1–3 days, the cells are disrupted and analysed for HSV type 1 or 2 antigens by an enzyme-linked immunosorbent assay. Antigens corresponding to 17 plaque-forming units were detectable after 1 day of incubation. After 3 days, HSV antigens derived from less than one plaqueforming unit were measurable. The sensitivities of 22 HSV-1 and 19 HSV-2 primary isolates from untreated patients were tested against adenosine arabinoside, acyclovir, phosphonoformic acid and iododeoxyuridine. Each isolate was found to have an individual pattern of sensitivities to the different antivirals. Five isolates were judged to be relatively resistant to one or more of the drugs tested.
doi_str_mv 10.1016/0166-0934(83)90026-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80533509</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0166093483900265</els_id><sourcerecordid>13598031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-f5d660532e7fc540b69d780fe815723952b637671d5f8d56c05ebaf87b93dc103</originalsourceid><addsrcrecordid>eNqFkE1r3DAQhkVoSTZp_0EDOpXm4Ga0sj58CYSQtIVAL8mxCFsaZVVsy5Hkpfn38XaXHNvDMDDzzDvwEPKJwVcGTF4uJStoeP1F84sGYC0rcURWTKtmGev6HVm9ISfkNOffACAU58fkWHKQwGFFfl3TMW6xpwOWTXTUx0QdFkxDGMP4RMsGacYxhxK2obzQ6OkG04SZ5jBMPf6h25DmTEuk7bhjUttTG4cpzqPLH8h73_YZPx76GXm8u324-V7d__z24-b6vrI1U6XywkkJgq9ReStq6GTjlAaPmgm15o1Yd5IrqZgTXjshLQjsWq9V13BnGfAz8nmfO6X4PGMuZgjZYt-3I8Y5G72Ec7GI-B_IuGg0cLaA9R60Keac0JsphaFNL4aB2ek3O7dm59Zobv7qN2I5Oz_kz92A7u3o4HvZX-33uNjYBkwm24CjRRcS2mJcDP9-8Ar4jpRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>13598031</pqid></control><display><type>article</type><title>A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wahren, B. ; Harmenberg, J. ; Sundqvist, V.-A. ; Levén, B. ; Sköldenberg, B.</creator><creatorcontrib>Wahren, B. ; Harmenberg, J. ; Sundqvist, V.-A. ; Levén, B. ; Sköldenberg, B.</creatorcontrib><description>A rapid and sensitive assay was developed to analyse the sensitivity of wild type HSV-1 and HSV-2 isolates with respect to a battery of antiviral substances. In the viral sensitivity assay, human embryonic lung fibroblasts are incubated with the virus isolate and different concentrations of the antivirals. After 1–3 days, the cells are disrupted and analysed for HSV type 1 or 2 antigens by an enzyme-linked immunosorbent assay. Antigens corresponding to 17 plaque-forming units were detectable after 1 day of incubation. After 3 days, HSV antigens derived from less than one plaqueforming unit were measurable. The sensitivities of 22 HSV-1 and 19 HSV-2 primary isolates from untreated patients were tested against adenosine arabinoside, acyclovir, phosphonoformic acid and iododeoxyuridine. Each isolate was found to have an individual pattern of sensitivities to the different antivirals. Five isolates were judged to be relatively resistant to one or more of the drugs tested.</description><identifier>ISSN: 0166-0934</identifier><identifier>EISSN: 1879-0984</identifier><identifier>DOI: 10.1016/0166-0934(83)90026-5</identifier><identifier>PMID: 6306030</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antigens, Viral - analysis ; Antiviral Agents - pharmacology ; antiviral substances ; Enzyme-Linked Immunosorbent Assay ; herpes simplex virus 1 ; herpes simplex virus 2 ; herpes simplex viruses ; Microbial Sensitivity Tests - methods ; Simplexvirus - drug effects</subject><ispartof>Journal of virological methods, 1983-01, Vol.6 (3), p.141-149</ispartof><rights>1983</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-f5d660532e7fc540b69d780fe815723952b637671d5f8d56c05ebaf87b93dc103</citedby><cites>FETCH-LOGICAL-c417t-f5d660532e7fc540b69d780fe815723952b637671d5f8d56c05ebaf87b93dc103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0166-0934(83)90026-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6306030$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wahren, B.</creatorcontrib><creatorcontrib>Harmenberg, J.</creatorcontrib><creatorcontrib>Sundqvist, V.-A.</creatorcontrib><creatorcontrib>Levén, B.</creatorcontrib><creatorcontrib>Sköldenberg, B.</creatorcontrib><title>A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds</title><title>Journal of virological methods</title><addtitle>J Virol Methods</addtitle><description>A rapid and sensitive assay was developed to analyse the sensitivity of wild type HSV-1 and HSV-2 isolates with respect to a battery of antiviral substances. In the viral sensitivity assay, human embryonic lung fibroblasts are incubated with the virus isolate and different concentrations of the antivirals. After 1–3 days, the cells are disrupted and analysed for HSV type 1 or 2 antigens by an enzyme-linked immunosorbent assay. Antigens corresponding to 17 plaque-forming units were detectable after 1 day of incubation. After 3 days, HSV antigens derived from less than one plaqueforming unit were measurable. The sensitivities of 22 HSV-1 and 19 HSV-2 primary isolates from untreated patients were tested against adenosine arabinoside, acyclovir, phosphonoformic acid and iododeoxyuridine. Each isolate was found to have an individual pattern of sensitivities to the different antivirals. Five isolates were judged to be relatively resistant to one or more of the drugs tested.</description><subject>Antigens, Viral - analysis</subject><subject>Antiviral Agents - pharmacology</subject><subject>antiviral substances</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>herpes simplex virus 1</subject><subject>herpes simplex virus 2</subject><subject>herpes simplex viruses</subject><subject>Microbial Sensitivity Tests - methods</subject><subject>Simplexvirus - drug effects</subject><issn>0166-0934</issn><issn>1879-0984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1r3DAQhkVoSTZp_0EDOpXm4Ga0sj58CYSQtIVAL8mxCFsaZVVsy5Hkpfn38XaXHNvDMDDzzDvwEPKJwVcGTF4uJStoeP1F84sGYC0rcURWTKtmGev6HVm9ISfkNOffACAU58fkWHKQwGFFfl3TMW6xpwOWTXTUx0QdFkxDGMP4RMsGacYxhxK2obzQ6OkG04SZ5jBMPf6h25DmTEuk7bhjUttTG4cpzqPLH8h73_YZPx76GXm8u324-V7d__z24-b6vrI1U6XywkkJgq9ReStq6GTjlAaPmgm15o1Yd5IrqZgTXjshLQjsWq9V13BnGfAz8nmfO6X4PGMuZgjZYt-3I8Y5G72Ec7GI-B_IuGg0cLaA9R60Keac0JsphaFNL4aB2ek3O7dm59Zobv7qN2I5Oz_kz92A7u3o4HvZX-33uNjYBkwm24CjRRcS2mJcDP9-8Ar4jpRs</recordid><startdate>19830101</startdate><enddate>19830101</enddate><creator>Wahren, B.</creator><creator>Harmenberg, J.</creator><creator>Sundqvist, V.-A.</creator><creator>Levén, B.</creator><creator>Sköldenberg, B.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19830101</creationdate><title>A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds</title><author>Wahren, B. ; Harmenberg, J. ; Sundqvist, V.-A. ; Levén, B. ; Sköldenberg, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-f5d660532e7fc540b69d780fe815723952b637671d5f8d56c05ebaf87b93dc103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Antigens, Viral - analysis</topic><topic>Antiviral Agents - pharmacology</topic><topic>antiviral substances</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>herpes simplex virus 1</topic><topic>herpes simplex virus 2</topic><topic>herpes simplex viruses</topic><topic>Microbial Sensitivity Tests - methods</topic><topic>Simplexvirus - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wahren, B.</creatorcontrib><creatorcontrib>Harmenberg, J.</creatorcontrib><creatorcontrib>Sundqvist, V.-A.</creatorcontrib><creatorcontrib>Levén, B.</creatorcontrib><creatorcontrib>Sköldenberg, B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of virological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wahren, B.</au><au>Harmenberg, J.</au><au>Sundqvist, V.-A.</au><au>Levén, B.</au><au>Sköldenberg, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds</atitle><jtitle>Journal of virological methods</jtitle><addtitle>J Virol Methods</addtitle><date>1983-01-01</date><risdate>1983</risdate><volume>6</volume><issue>3</issue><spage>141</spage><epage>149</epage><pages>141-149</pages><issn>0166-0934</issn><eissn>1879-0984</eissn><abstract>A rapid and sensitive assay was developed to analyse the sensitivity of wild type HSV-1 and HSV-2 isolates with respect to a battery of antiviral substances. In the viral sensitivity assay, human embryonic lung fibroblasts are incubated with the virus isolate and different concentrations of the antivirals. After 1–3 days, the cells are disrupted and analysed for HSV type 1 or 2 antigens by an enzyme-linked immunosorbent assay. Antigens corresponding to 17 plaque-forming units were detectable after 1 day of incubation. After 3 days, HSV antigens derived from less than one plaqueforming unit were measurable. The sensitivities of 22 HSV-1 and 19 HSV-2 primary isolates from untreated patients were tested against adenosine arabinoside, acyclovir, phosphonoformic acid and iododeoxyuridine. Each isolate was found to have an individual pattern of sensitivities to the different antivirals. Five isolates were judged to be relatively resistant to one or more of the drugs tested.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>6306030</pmid><doi>10.1016/0166-0934(83)90026-5</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-0934
ispartof Journal of virological methods, 1983-01, Vol.6 (3), p.141-149
issn 0166-0934
1879-0984
language eng
recordid cdi_proquest_miscellaneous_80533509
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antigens, Viral - analysis
Antiviral Agents - pharmacology
antiviral substances
Enzyme-Linked Immunosorbent Assay
herpes simplex virus 1
herpes simplex virus 2
herpes simplex viruses
Microbial Sensitivity Tests - methods
Simplexvirus - drug effects
title A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T06%3A06%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20method%20for%20determining%20the%20sensitivity%20of%20herpes%20simplex%20virus%20to%20antiviral%20compounds&rft.jtitle=Journal%20of%20virological%20methods&rft.au=Wahren,%20B.&rft.date=1983-01-01&rft.volume=6&rft.issue=3&rft.spage=141&rft.epage=149&rft.pages=141-149&rft.issn=0166-0934&rft.eissn=1879-0984&rft_id=info:doi/10.1016/0166-0934(83)90026-5&rft_dat=%3Cproquest_cross%3E13598031%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=13598031&rft_id=info:pmid/6306030&rft_els_id=0166093483900265&rfr_iscdi=true